Dermatitis, Atopic  >>  GSK870086 inhalation  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK870086 inhalation / GSK
NCT01299610: A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

Completed
2
25
Europe
GW870086 2.0%, GW870086 0.2%, FP 0.05%, Placebo
GlaxoSmithKline
Dermatitis, Atopic
03/11
04/11

Download Options